Rene Letourneau
National health spending in July grew 4.2 percent relative to July 2011, up from the 3.9 percent growth rate experienced in June, according to the Health Sector Economic Indicators brief released recently by the Altarum Institute’s Center for Sustainable Health Spending.
As a full-time consumer and part-time conspiracy theorist, I’ve often wondered how meaningful an FDA approval really is. How much trust can I place in their endorsement of the products I buy and the foods I eat?
The use of generic prescription drugs has risen to a current rate of $1 billion every other day, saving the U.S. healthcare system more than $1 trillion over the last 10 years (2002-2011), according to a report released Aug. 2 by the Generic Pharmaceutical Association (GPhA).
When the Centers for Medicare & Medicaid announced a one-year delay for ICD-10 implementation in February 2012 – pushing the date back to Oct. 1, 2014 – some industry groups cheered, others jeered. What did CFOs do? The smart ones kept their focus and pushed forward with their implementation plans and schedules.
Filling nursing shifts at the last minute is a nearly constant battle for many unit managers. Some industry experts say automated workforce management tools can offer significant relief for this time-intensive challenge; others say the use of these tools should not be viewed as a best practice.
Overall U.S. healthcare prices increased nearly a full percentage point from July to August 2012, rising 0.9 percent, according to the federal Bureau of Labor Statistics.
Based on information examined in its Budget Impact Projections report and the National Economic Impact Survey, supply contracting company Novation predicts supply chain costs will increase by 2.9 percent in 2013.
Medical device firm Welch Allyn announced Monday it will reduce its workforce by 10 percent over the next three years in reaction to the 2.3 percent medical device tax slated to begin in January 2013 in accordance with the Affordable Care Act.
The market for products designed to test for hospital-acquired infections (HAIs) grew 10 percent in 2011 to reach $1.2 billion, according to a new report from healthcare market research firm Kalorama Information.
In a report released Thursday, the FDA outlined a four-step plan to better monitor and report on the effectiveness and safety of medical devices.